Journal profile · Cardiac & Cardiovascular Systems
European Heart Journal Supplements
ISSN 1520-765X · eISSN 1554-2815 · Oxford University Press · ENGLAND · Semimonthly · Founded 1999
European Heart Journal Supplements: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.63; subscription journal; review about 12 months (community reports); community-reported acceptance: about 25%; 855 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
European Heart Journal Supplements is published by Oxford University Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cardiac Valve Diseases and Treatments, Cardiac Imaging and Diagnostics and Atrial Fibrillation Management and Outcomes, together about 19.9% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The European Heart Journal Supplements (EHJs) is a long standing member of the ESC Journal Family that serves as a publication medium for supplemental issues of the flagship European Heart Journal. Traditionally EHJs published a broad range of articles from symposia to special issues on specific topics of interest. The Editor-in-Chief, Professor Roberto Ferrari, together with his team of eminent Associate Editors: Professor Francisco Fernández-Avilés, Professors Jeroen Bax, Michael Böhm, Frank Ruschitzka, and Thomas Lüscher from the European Heart Journal, has implemented a change of focus for the journal. This entirely refreshed version of the European Heart Journal Supplements now bears the subtitle the Heart of the Matter to give recognition to the focus the journal now has. The EHJs – the Heart of the Matter intends to offer a dedicated, scientific space for the ESC, Institutions, National and Affiliate Societies, Associations, Working Groups and Councils to disseminate their important successes globally.
Source: LetPub
Research area (LetPub): Cardiac & Cardiovascular Systems
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cardiac Valve Diseases and TreatmentsMedicine6.9%
- Cardiac Imaging and DiagnosticsMedicine6.6%
- Atrial Fibrillation Management and OutcomesMedicine6.4%
- Cardiovascular Function and Risk FactorsMedicine6.4%
- Cardiac Arrhythmias and TreatmentsMedicine5.7%
- Cardiac pacing and defibrillation studiesMedicine5.3%
- Coronary Interventions and DiagnosticsMedicine4.3%
- Cardiac Structural Anomalies and RepairMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.63LetPub ·
- CiteScore 2026-06
- 4LetPub ·
- SJR 2026-06
- 0.8LetPub ·
- SNIP 2026-06
- 0.85LetPub ·
- h-index
- 33LetPub ·
- h-index
- 55OpenAlex ·
- i10-index
- 600OpenAlex ·
- 2-year mean citedness
- 0.27OpenAlex ·
- Self-citation rate
- 7.4%LetPub ·
- Share of gold OA articles
- 97.16%LetPub ·
Volume
- Articles per year
- 112LetPub ·
Articles by year OpenAlex count · 7,890 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,139 | 317 | 15 |
| 2025 | 855 | 308 | 339 |
| 2024 | 592 | 396 | 338 |
| 2023 | 715 | 713 | 1,539 |
| 2022 | 1,415 | 1,129 | 1,147 |
| 2021 | 1,060 | 712 | 1,177 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 12 monthsLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Semimonthly
- Founded
- 1999
- ISSN
- 1520-765X
- Electronic ISSN
- 1554-2815
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about European Heart Journal Supplements
What CAS zone is European Heart Journal Supplements in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Heart Journal Supplements is in Zone 4 of Medicine, and in Zone 4 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Heart Journal Supplements?
The latest impact factor listed by LetPub is 2.63; CiteScore 4, h-index 55.
How long does peer review take at European Heart Journal Supplements?
Authors report an average review time of about 12 months; the community-reported acceptance is “about 25%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index European Heart Journal Supplements?
According to LetPub and DOAJ records, European Heart Journal Supplements is indexed in SCIE and Scopus.
Is European Heart Journal Supplements open access, and what is the APC?
European Heart Journal Supplements is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .